Analyst Ratings for Zynerba Pharmaceuticals (ZYNE)

ZYNE Rating Summary

  |   Expand Research on ZYNE
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 3.6 / 10   Percentile Rank: 34%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
8/16/2023 Canaccord Sumant Kulkarni Downgrade Hold
(Buy)		 1.11
(10.00)		 1.35
(1.30)		 -3.7% Details
8/15/2023 H.C. Wainwright N/A Downgrade Neutral
(Buy)		 N/A
(N/A)		 1.35
(1.30)		 -3.7% Details